Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion

İbrahim Serhat Karakuş(Marmara University), Safa Barış(Marmara University)
Journal of Clinical Immunology
April 5, 2024
Cited by 5


Related Papers